Conexeu Sciences Inc.

BiotechnologyBiotechnologyRegenerative MedicineTissue Regeneration

📍 Reno, NV, USA

StreetZero Signal 73

Be the first to signal interest

About Conexeu Sciences Inc.

Conexeu Sciences Inc. is a biotechnology company revolutionizing tissue regeneration with its patented collagen flowable gel platform. Emerging from over a decade of university research, the company is developing this technology for applications in wound care, medical fields, and broader verticals. Based in Reno, Nevada, it recently completed a $5 million Regulation Crowdfunding financing via the Equifund platform.

LATEST FUNDINGPrivate Placement

$1.5M

Announced 2026-10-21

TOTAL RAISED$6.96M

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Conexeu Sciences Inc..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES—

FOUNDED—

HQReno, NV, USA

Industry

Biotechnology

Investors

Equifund

Key highlights

Completed $5M Reg CF financing in less than two weeks via Equifund platform.
Developing patented collagen flowable gel for tissue regeneration from university research.
Total funding reported at $6.96M over 9 rounds by Tracxn.
Funds targeted at development and commercialization across multiple verticals.
Located in Reno, NV with focus on wound care and regenerative applications.

Ask StreetZero about Conexeu Sciences Inc.

Put our AI to work on this deal.

What is Conexeu Sciences Inc.'s value proposition?Who are Conexeu Sciences Inc.'s competitors?Why does this raise matter?Summarize Conexeu Sciences Inc. for an investor.

Similar companies

Other Biotechnology deals, ranked by Signal.

Allyx Therapeutics, Inc.

$27.9M

Estuary Biotherapeutics, Inc.

$40.7M

Kaigene, Inc.

$55.0M

CURADEL SURGICAL INNOVATIONS, INC.

$49.8M

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.